Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 Jan;38(1):503-9.
doi: 10.1007/s11033-010-0134-y. Epub 2010 Apr 1.

Characterization of peptidoglycan hydrolase in Cag pathogenicity island of Helicobacter pylori

Affiliations

Characterization of peptidoglycan hydrolase in Cag pathogenicity island of Helicobacter pylori

Qiao Zhong et al. Mol Biol Rep. 2011 Jan.

Abstract

The Cag Type IV secretion apparatus proteins in Helicobacter pylori can mediate the injection of effector CagA protein into eukaryotic target cells. Although this apparatus forms an important pathway for bacterium-host interaction, its assembly process in vivo is poorly understood, and the proteins which contribute to break the bacterial cell walls in Cag-PAI have not yet been identified. The cagγ gene in Cag-PAI is a unique member that contains a conserved SLT catalysis domain, which makes it an attracting question whether cagy gene has the capacity to digest the bacterial cell wall. In the current study, therefore, the cagγ gene was cloned from the H. pylori NCTC 11637 and expressed in Escherichia coli, and its lytic effect on cell walls in vitro was observed. Results indicated that Cagγ protein has a lytic activity against bacterial cell walls. An allelic-exchange mutant (Δcagγ) was further constructed to investigate the relationship between Cagγ and effector CagA translocation. These results suggested that Cagγ contributed to the assembly of Cag Type IV secretion apparatus by digesting the peptidoglycan meshwork of bacterial cell walls.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Biochem Pharmacol. 2007 Jun 1;73(11):1697-702 - PubMed
    1. Mol Biol Rep. 2011 Jun;38(5):3173-80 - PubMed
    1. Infect Disord Drug Targets. 2007 Mar;7(1):19-27 - PubMed
    1. Cell Microbiol. 2008 Dec;10(12):2377-86 - PubMed
    1. J Bacteriol. 2005 Aug;187(15):5397-405 - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources